GP-D |
3-(Morpholin-4-ylmethyl)-1,5-dihydro-6H-[1,2]diazepino[4,5,6-cd]indol-6-one |
0.17±0.03 |
PJ34 |
N-(6-oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide |
0.28±0.07 |
GP-M |
N-(6-oxo-5,6-dihydrobenzo[c][1,5]naphthyridin-2-yl)-2-(4-pyrrolidin-1-ylpiperidin-1-yl)acetamide-HCl |
0.29±0.04 |
GP-P |
1,11b-Dihydro-[1]benzopyrano[4,3,2-de]isoquinolin-3(2H)-one-10-sulphonic acid |
0.45±0.02 |
GP-F |
1-[4-(3-Dimethylamino-propoxy)-phenyl]-8,9-dihydro-7H-2,7,9a-triaza-benzo[cd]azulen-6-one-HCl |
0.48±0.04 |
GP-L |
8-Fluoro-2-(3-piperidin-1-ylpropanoyl)-1,3,4,5-2H-tetrahydrobenzo[c]-1,6-naphthyridin-6-one-MsOH |
0.61±0.14 |
GP-G |
2-(4-Methylpiperazin-1-yl)-5H-benzo[c][1,5]naphthyridin-6-one-MsOH |
0.69±0.13 |
GP-H |
1-Dimethylaminomethyl-8,9-dihydro-7H-2,7,9a-triaza-benzo[cd]azulen-6-one-HCl |
0.96±0.05 |
GP-N |
2-(4-Isopropylpiperazin-1-yl)-5H-benzo[c][1,5]naphthyridin-6-one-MsOH |
1.05±0.04 |
GP-I |
1-[2-(4-Pyrrolidin-1-ylmethyl-phenyl)-ethyl]-8,9-dihydro-7H-2,7,9a-triaza-benzo[cd]azulen-6-one hydrochloride-HCl |
4.46±0.95 |
5-AIQ |
5-Amino-isoquinoline-HCl |
22.8±2.7 |